Our program was initially started in 2016 with the mission of reimagining how men can be more easily treated for one of the most common disease states in the world affecting men, Benign Prostatic Hyperplasia (BPH). Prodeon Medical, Inc. has developed and is investigating a minimally invasive and patient-friendly approach to treating Lower Urinary Tract Symptoms (LUTS) due to BPH 
The procedure, known as the PURE™ (Prostatic Urethral REshaping) procedure uses the investigational the Urocross™ Expander System and Retrieval Sheath to relieve symptoms associated with BPH.

Caution: The Urocross Expander System and Retrieval Sheath are for investigational use only under the Expander-2 Clinical Trial (NCT: 05400980) and are not for sale in the U.S. or outside the U.S.

Health Care

Biotechnology

Medical Devices

Prodeon Medical, Inc.

Paul M. Edwards

Dan Condon

Jayachandran Ravichandran

Craig Purdy

Kimberly Marquez

Ted McKittrick Acrp-Cp

Clinical Research Team

Leadership Team

Prodeon Medical, Inc.

Org chart

Teams

Clinical Research Team

Leadership Team

Similar companies